Introduction to RNA-seq and its applications to drug discovery and development

Drug Development Research

Volumn 75, Issue 5, 2014, Pages 324-330

  Khatoon, Zainab ^a   Figler, Bryan ^b   Zhang, Hui ^c   Cheng, Feng ^d  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

drug resistance; fusion protein; microarray; miRNA; next generation sequencing; RNA Seq

Indexed keywords

MICRORNA; TRANSCRIPTOME;

BINOMIAL DISTRIBUTION; DRUG DEVELOPMENT; DRUG RESISTANCE; FUSION GENE; GENE IDENTIFICATION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; POISSON DISTRIBUTION; PROTEIN ANALYSIS; REVIEW; RNA SEQUENCE; HIGH THROUGHPUT SEQUENCING; SEQUENCE ANALYSIS;

DRUG DISCOVERY; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; SEQUENCE ANALYSIS, RNA; TRANSCRIPTOME;

EID: 84906655629     PISSN: 02724391     EISSN: 10982299     Source Type: Journal    
DOI: 10.1002/ddr.21215     Document Type: Review

References (34)

1. Anders S, Huber W,. 2010. Differential expression analysis for sequence count data. Genome Biol 11: R106.
2. Auer PL, Srivastava S, Doerge RW,. 2012. Differential expression-the next generation and beyond. Brief Funct Genomics 11: 57-62.
3. Courcelle J, Khodursky A, Peter B, Brown P, Hanawalt P,. 2001. Comparative gene expression profiles following UV exposure in wild type and SOS-deficient Escherichia coli. Genetics 158: 41-64.
4. Dhamgaye S, Bernard M, Lelandais G, Sismeiro O, Lemoine S, Coppee JY, Le Crom S, Prasad R, Devaux F,. 2012. RNA sequencing revealed novel actors of the acquisition of drug resistance in Candida albicans. BMC Genomics 13: 396.
5. Dillies MA, Rau A, Aubert J, Hennequet-Antier C, Jeanmougin M, Servant N, Keime C, Marot G, Castel D, Estelle J, et al. 2013. A comprehensive evaluation of normalization methods for Illumina high-throughput RNA sequencing data analysis. Brief Bioinform 14: 671-683.
6. Edgren H, Murumagi A, Kangaspeska S, Nicorici D, Hongisto V, Kleivi K, Rye IH, Nyberg S, Wolf M, Borresen-Dale AL, et al. 2011. Identification of fusion genes in breast cancer by paired-end RNA-sequencing. Genome Biol 12: R6.
7. Famoye F, Wulu J, Singh KP,. 2004. On the generalized poisson regression model with an application to accidental data. J Data Sci 2: 287-295.
8. Garber M, Grabherr MG, Guttman M, Trapnell C,. 2011. Computational methods for transcriptome annotation and quantification using RNA-seq. Nat Methods 8: 469-477.
9. Ge H, Liu K, Juan T, Fang F, Newman M, Hoeck W,. 2011. FusionMap: detecting fusion genes from next-generation sequencing data at base-pair resolution. Bioinformatics 27: 1922-1928.
10. Hardcastle TJ, Kelly KA,. 2010. baySeq: empirical Bayesian methods for identifying differential expression in sequence count data. BMC Bioinformatics 11: 422.
11. Iyer MK, Chinnaiyan AM, Maher CA,. 2011. ChimeraScan: a tool for identifying chimeric transcription in sequencing data. Bioinformatics 27: 2903-2904.
12. Jia W, Qiu K, He M, Song P, Zhou Q, Zhou F, Yu Y, Zhu D, Nickerson ML, Wan S, et al. 2013. SOAPfuse: an algorithm for identifying fusion transcripts from paired-end RNA-Seq data. Genome Biol 14: R12.
13. Kim D, Salzberg SL,. 2011. TopHat-Fusion: an algorithm for discovery of novel fusion transcripts. Genome Biol 12: R72.
14. Kim J, Noh J, Park W,. 2013. Insight into norfloxacin resistance of Acinetobacter oleivorans DR1: target gene mutation, persister, and RNA-Seq analyses. J Microbiol Biotechnol 23: 1293-1303.
15. Kutanzi KR, Yurchenko OV, Beland FA, Checkhun VF, Pogribny IP,. 2011. MicroRNA-mediated drug resistance in breast cancer. Clin Epigenetics 2: 171-185.
16. Liu C, Ma J, Chang CJ, Zhou X,. 2013. FusionQ: a novel approach for gene fusion detection and quantification from paired-end RNA-Seq. BMC Bioinformatics 14: 193.
17. Maher CA, Kumar-Sinha C, Cao X, Kalyana-Sundaram S, Han B, Jing X, Sam L, Barrette T, Palanisamy N, Chinnaiyan AM,. 2009. Transcriptome sequencing to detect gene fusions in cancer. Nature 458: 97-101.
18. McPherson A, Hormozdiari F, Zayed A, Giuliany R, Ha G, Sun MG, Griffith M, Heravi Moussavi A, Senz J, Melnyk N, et al. 2011. deFuse: an algorithm for gene fusion discovery in tumor RNA-Seq data. PLoS Comput Biol 7: e1001138.
19. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B,. 2008. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 5: 621-628.
20. Pan J, Zhang Q, Xiong D, Vedell P, Yan Y, Jiang H, Cui P, Ding F, Tichelaar JW, Wang Y, et al. 2014. Transcriptomic analysis by RNA-seq reveals AP-1 pathway as key regulator that green tea may rely on to inhibit lung tumorigenesis. Mol Carcinog 53: 19-29.
21. Pan W,. 2002. A comparative review of statistical methods for discovering differentially expressed genes in replicated microarray experiments. Bioinformatics 18: 546-554.
22. Pounds S, Rai SN,. 2009. Assumption adequacy averaging as a concept to develop more robust methods for differential gene expression analysis. Comput Stat Data Anal 53: 1604-1612.
23. Pounds SB, Gao CL, Zhang H,. 2012. Empirical bayesian selection of hypothesis testing procedures for analysis of sequence count expression data. Stat Appl Genet Mol Biol 11: 1544-6115.
24. Quinn EM, Cormican P, Kenny EM, Hill M, Anney R, Gill M, Corvin AP, Morris DW,. 2013. Development of strategies for SNP detection in RNA-seq data: application to lymphoblastoid cell lines and evaluation using 1000 Genomes data. PLoS ONE 8: e58815.
25. Ren S, Peng Z, Mao JH, Yu Y, Yin C, Gao X, Cui Z, Zhang J, Yi K, Xu W, et al. 2012. RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicings. Cell Res 22: 806-821.
26. Robinson MD, Smyth GK,. 2008. Small-sample estimation of negative binomial dispersion, with applications to SAGE data. Biostatistics 9: 321-332.
27. Robinson MD, McCarthy DJ, Smyth GK,. 2010. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26: 139-140.
28. Srivastava S, Chen L,. 2010. A two-parameter generalized Poisson model to improve the analysis of RNA-seq data. Nucleic Acids Res 38: e170.
29. Wang Z, Gerstein M, Snyder M,. 2009. RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet 10: 57-63.
30. Wang Z, Li Y, Ahmad A, Azmi AS, Kong D, Banerjee S, Sarkar FH,. 2010. Targeting miRNAs involved in cancer stem cell and EMT regulation: an emerging concept in overcoming drug resistance. Drug Resist Update 13: 109-118.
31. Xu Y, Ohms SJ, Li Z, Wang Q, Gong G, Hu Y, Mao Z, Shannon MF, Fan JY,. 2013. Changes in the expression of miR-381 and miR-495 are inversely associated with the expression of the MDR1 gene and development of multi-drug resistance. PLoS ONE 8: e82062.
32. Yang ZH, Zheng R, Gao Y, Zhang Q, Zhang H,. 2014. Abnormal gene expression and gene fusion in lung adenocarcinoma with high-throughput RNA sequencing. Cancer Gene Ther 21: 74-82.
33. Zhang H, Yu Q, Feng C, Gunzler D, Wu P, Tu XM,. 2012. A new look at the difference between the GEE and the GLMM when modeling longitudinal count responses. J Appl Stat 39: 2067-2079.
34. Zhang J, Wang Y, Zhen P, Luo X, Zhang C, Zhou L, Lu Y, Yang Y, Zhang W, Wan J,. 2013. Genome-wide analysis of miRNA signature differentially expressed in doxorubicin-resistant and parental human hepatocellular carcinoma cell lines. PLoS ONE 8: e54111.